このエントリーをはてなブックマークに追加
ID 53537
Sort Key
9
Title Alternative
A prospective cohort study to define the clinical and pathological features of lung cancers harboring HER2 gene aberrations (the HER2-CS Study) and a phase II study of trastuzumab emtansine (recombinant) in patients with HER2-positive non-small cell lung cancer who recurred, progressed after standard chemotherapy, or were primarily refractory to standard chemotherapy
FullText URL
Thumnail 127_127.pdf 1.69 MB
Author
Kiura, Katsuyuki Kaken ID researchmap
Sato, Akiko
Ninomiya, Takashi
Hirata, Taizo
Keywords
臨床研究中核病院
国立研究開発法人日本医療研究開発機構
文部科学省橋渡し研究加速ネットワークプログラム
HER2-CS study
trastuzumab emtansine
Note
特集(Feature Articles)
Publication Title
岡山医学会雑誌
Published Date
2015-08-03
Volume
volume127
Issue
issue2
Publisher
岡山医学会
Publisher Alternative
Okayama Medical Association
Start Page
127
End Page
132
ISSN
0030-1558
NCID
AN00032489
Content Type
Journal Article
Related Url
isVersionOf https://doi.org/10.4044/joma.127.127
OAI-PMH Set
岡山大学
language
日本語
Copyright Holders
Copyright (c) 2015 岡山医学会
File Version
publisher
Refereed
True
DOI
NAID
Eprints Journal Name
joma